LMRT research drives hepatitis research forward with induced pluripotent stem cells

February 1, 2012

Stem cells could drive hepatitis research forward. Research out of the lab (see Schwartz et al, PNAS 2012) has established heptatitis C virus infection in liver-like cells derived from induced pluripotent stem cells (iPSCs), work that has been covered widely in the press, including MIT News.


Other coverage includes: